Company / Working Capital
Metagenomi Therapeutics, Inc. Working Capital History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$142.6M
FY2025
5-year range
$142.6M / $220.7M
FY2024-FY2025
Trend
-35.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$143M in FY2025.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 35.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.90 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $142.6M | -35.4% |
| FY2024 | $220.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026